Mesa Laboratories (MLAB) Short Interest Ratio & Short Volume → He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (From InvestorPlace) (Ad) Free MLAB Stock Alerts $121.56 -0.66 (-0.54%) (As of 05:19 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Mesa Laboratories Short Interest DataCurrent Short Interest150,100 sharesPrevious Short Interest156,000 sharesChange Vs. Previous Month-3.78%Dollar Volume Sold Short$15.92 millionShort Interest Ratio3.6 Days to CoverLast Record DateApril 30, 2024Outstanding Shares5,390,000 sharesPercentage of Shares Shorted2.78%Today's Trading Volume20,214 sharesAverage Trading Volume44,686 sharesToday's Volume Vs. Average45% Short Selling Mesa Laboratories ? Sign up to receive the latest short interest report for Mesa Laboratories and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMLAB Short Interest Over TimeMLAB Days to Cover Over TimeMLAB Percentage of Float Shorted Over Time Ad InvestorPlaceBoost your retirement with these AI payoutsBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. Mesa Laboratories Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024150,100 shares $15.92 million -3.8%N/A3.6 $106.08 4/15/2024156,000 shares $16.29 million -18.3%N/A3.5 $104.45 3/31/2024191,000 shares $20.96 million -2.7%N/A3.9 $109.73 3/15/2024196,300 shares $19.84 million -17.2%N/A3.7 $101.08 2/29/2024237,200 shares $25.90 million +3.9%N/A4 $109.19 2/15/2024228,200 shares $23.79 million +2.2%N/A3.8 $104.27 Get the Latest News and Ratings for MLAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024223,200 shares $20.45 million +3.5%N/A3.8 $91.62 1/15/2024215,600 shares $20.69 million -4.9%N/A3.9 $95.96 12/31/2023226,800 shares $23.76 million -1.5%N/A4.3 $104.77 12/15/2023230,200 shares $25.41 million -21.9%N/A4.7 $110.37 11/30/2023294,600 shares $25.15 million +0.2%N/A6.8 $85.37 11/15/2023293,900 shares $27.56 million -0.7%N/A7.3 $93.77 10/31/2023295,900 shares $27.76 million +5.5%N/A7.9 $93.83 10/15/2023280,500 shares $28.46 million -15.1%N/A7.9 $101.45 9/30/2023330,400 shares $34.72 million -7.1%N/A9.3 $105.07 9/15/2023355,700 shares $43.72 million -1.8%N/A10.5 $122.91 8/31/2023362,300 shares $51.94 million +5.1%N/A9.6 $143.36 8/15/2023344,800 shares $48.25 million -0.7%N/A7.9 $139.93 7/31/2023347,200 shares $44.67 million -2.7%N/A7.5 $128.66 7/15/2023356,700 shares $43.65 million -8.7%N/A7.6 $122.36 6/30/2023390,500 shares $50.18 million -4.9%N/A8.1 $128.50 6/15/2023410,700 shares $55.22 million -4.8%N/A8.4 $134.45 5/31/2023431,500 shares $55.87 million -3.3%N/A9.2 $129.49 5/15/2023446,300 shares $70.52 million -4.3%8.7%10.1 $158.01 4/30/2023466,400 shares $77.66 million +3.8%9.1%10.1 $166.51 4/15/2023449,300 shares $74.05 million +2.5%8.8%8.3 $164.82 3/31/2023438,200 shares $76.57 million -3.1%8.5%7.6 $174.73 3/15/2023452,100 shares $75.89 million -3.8%8.8%7 $167.87 2/28/2023469,900 shares $82.95 million +7.5%9.2%6.4 $176.52 2/15/2023437,100 shares $77.70 million +2.7%8.5%5.7 $177.76 1/31/2023425,600 shares $82.80 million -2.1%8.3%5.2 $194.54 1/15/2023434,900 shares $82.85 million +9.5%8.5%5.5 $190.51 12/30/2022397,300 shares $66.04 million -3.8%7.8%5.2 $166.21 12/15/2022413,000 shares $68.76 million +6.6%8.1%5.6 $166.49 11/30/2022387,600 shares $65.57 million +3.7%7.6%5.5 $169.17 11/15/2022373,900 shares $70.61 million +17.5%7.3%5.4 $188.84 10/31/2022318,300 shares $42.08 million +7.9%6.2%4.9 $132.21 10/15/2022295,100 shares $37.33 million +0.6%5.8%5 $126.51 9/30/2022293,400 shares $41.32 million -13.3%5.8%5.3 $140.83 9/15/2022338,500 shares $53.82 million -10.1%6.7%6.4 $159.00The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. 8/31/2022376,400 shares $64.31 million -7.3%7.4%7.7 $170.86 8/15/2022405,900 shares $81.04 million -11.2%8.0%9.8 $199.66 7/31/2022456,900 shares $97.43 million +0.8%9.0%12.2 $213.25 7/15/2022453,300 shares $89.98 million +2.5%9.0%12.1 $198.51 6/30/2022442,200 shares $90.18 million -1.1%8.8%12 $203.94 6/15/2022447,000 shares $82.95 million +22.5%8.8%13.1 $185.57 5/31/2022364,900 shares $76.36 million -0.4%7.2%12.7 $209.25 5/15/2022366,300 shares $79.85 million -1.0%7.2%13.7 $217.98 4/30/2022369,800 shares $79.00 million +2.2%7.3%13.9 $213.63 4/15/2022361,800 shares $90.45 million +6.9%7.2%14.2 $250.00 3/31/2022338,400 shares $86.25 million +5.4%6.7%13.9 $254.88 3/15/2022321,100 shares $80.72 million +6.0%6.4%14.5 $251.40 2/28/2022302,900 shares $77.34 million +1.0%6.0%12.4 $255.33 2/15/2022300,000 shares $77.34 million +2.1%6.0%12 $257.81 1/31/2022293,900 shares $83.56 million -2.0%5.8%10 $284.33 1/15/2022300,000 shares $88.85 million +1.0%6.0%10.6 $296.15 12/31/2021296,900 shares $97.41 million +2.2%5.9%9.3 $328.09 12/15/2021290,600 shares $94.60 million +0.9%5.8%8.6 $325.55 11/30/2021288,000 shares $88.93 million +50.9%5.7%7.5 $308.79 11/15/2021190,800 shares $58.53 million -2.5%3.8%5 $306.74 10/29/2021195,700 shares $59.83 million +9.0%3.9%5.8 $305.70 10/15/2021179,600 shares $55.63 million +3.9%3.6%5.6 $309.73 9/30/2021172,800 shares $52.25 million -4.7%3.5%6.6 $302.36 9/15/2021181,300 shares $53.84 million +8.1%3.6%6.4 $296.94 8/31/2021167,700 shares $44.76 million +0.1%3.4%7.5 $266.92 8/13/2021167,600 shares $46.71 million +9.0%3.4%7.4 $278.69 7/30/2021153,700 shares $45.27 million -11.5%3.1%6.8 $294.51 7/15/2021173,700 shares $48.48 million -7.4%3.5%7.6 $279.10 6/30/2021187,600 shares $50.87 million -7.4%3.8%7.4 $271.17 6/15/2021202,500 shares $53.32 million -8.2%4.1%8.1 $263.30 5/28/2021220,600 shares $54.28 million +3.7%4.5%8.4 $246.06 5/14/2021212,800 shares $52.63 million +5.9%N/A8.4 $247.30 4/30/2021201,000 shares $50.25 million -7.3%N/A7.3 $250.02 4/15/2021216,900 shares $55.81 million -23.0%N/A7.6 $257.33 3/31/2021281,700 shares $69.36 million -3.2%N/A10.3 $246.23 3/15/2021291,100 shares $77.52 million -3.8%N/A11.2 $266.29 2/26/2021302,700 shares $83.55 million +1.0%N/A12.2 $276.01 2/12/2021299,800 shares $85.05 million -5.4%N/A11.7 $283.69 1/29/2021316,900 shares $89.68 million -1.9%N/A12.4 $283.00 1/15/2021322,900 shares $95.90 million +1.5%N/A12.5 $297.01 12/31/2020318,100 shares $89.66 million -0.3%N/A12.3 $281.85 12/15/2020319,000 shares $88.54 million -8.6%N/A11.6 $277.56 11/30/2020349,100 shares $95.87 million +0.5%N/A11.3 $274.62 11/15/2020347,400 shares $97.45 million +0.6%N/A11.3 $280.51 10/30/2020345,200 shares $91.92 million -3.1%N/A11.2 $266.29 10/15/2020356,100 shares $98.60 million -1.6%N/A11.1 $276.89 9/30/2020361,700 shares $92.15 million +3.6%N/A10.4 $254.76 9/15/2020349,000 shares $86.02 million -3.2%N/A9.3 $246.48 8/31/2020360,600 shares $88.68 million +3.4%N/A8.5 $245.92 8/14/2020348,600 shares $84.47 million -2.0%N/A7.8 $242.31The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. 7/31/2020355,600 shares $84.26 million -2.4%N/A8 $236.94 7/15/2020364,300 shares $79.16 million -5.2%N/A8.1 $217.30 6/30/2020384,300 shares $81.54 million -12.6%N/A8.8 $212.19 6/15/2020439,800 shares $99.71 million -17.0%N/A10 $226.72 5/29/2020529,700 shares $139.97 million +4.8%N/A13.8 $264.25 5/15/2020505,600 shares $120.31 million -2.5%N/A12.9 $237.96 4/30/2020518,400 shares $125.88 million +0.1%N/A12.6 $242.83 4/15/2020518,000 shares $109.33 million -5.8%N/A12.5 $211.07 3/31/2020549,800 shares $126.07 million -8.8%N/A12.4 $229.30 3/13/2020602,500 shares $135.79 million -2.5%N/A15.3 $225.37 2/28/2020617,700 shares $117.79 million +4.5%N/A15.2 $190.69 2/14/2020591,100 shares $139.82 million +10.0%N/A15.4 $236.55 1/31/2020537,200 shares $137.99 million -0.4%N/A14.4 $256.87 1/15/2020539,600 shares $134.30 million -2.2%N/A15 $248.89 12/31/2019551,800 shares $146.23 million -1.4%N/A15.7 $265.00 8/15/2019606,200 shares $129.53 million +0.2%17.5%5.8 $213.68 7/31/2019606,200 shares $131.87 million +0.2%17.5%5.8 $217.53 MLAB Short Interest - Frequently Asked Questions What is Mesa Laboratories' current short interest? Short interest is the volume of Mesa Laboratories shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 150,100 shares of MLAB short. Learn More on Mesa Laboratories' current short interest. What is a good short interest ratio for Mesa Laboratories? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MLAB shares currently have a short interest ratio of 4.0. Learn More on Mesa Laboratories's short interest ratio. Is Mesa Laboratories' short interest increasing or decreasing? Mesa Laboratories saw a decline in short interest in April. As of April 30th, there was short interest totaling 150,100 shares, a decline of 3.8% from the previous total of 156,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Mesa Laboratories' short interest compare to its competitors? Here is how the short interest of companies compare to Mesa Laboratories: Savara Inc (6.37%), Silence Therapeutics plc (0.99%), Varex Imaging Co. (11.10%), Definitive Healthcare Corp. (5.10%), Quanterix Co. (3.84%), Lyell Immunopharma, Inc. (16.91%), EyePoint Pharmaceuticals, Inc. (12.67%), Mineralys Therapeutics, Inc. (4.46%), Pharming Group (0.01%), enGene Holdings Inc. (0.27%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Mesa Laboratories stock? Short selling MLAB is an investing strategy that aims to generate trading profit from Mesa Laboratories as its price is falling. MLAB shares are trading down $0.66 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mesa Laboratories? A short squeeze for Mesa Laboratories occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MLAB, which in turn drives the price of the stock up even further. How often is Mesa Laboratories' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MLAB, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Savara Short Interest Silence Therapeutics Short Interest Varex Imaging Short Interest Definitive Healthcare Short Interest Quanterix Short Interest Lyell Immunopharma Short Interest EyePoint Pharmaceuticals Short Interest Mineralys Therapeutics Short Interest Pharming Group Short Interest enGene Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MLAB) was last updated on 5/20/2024 by MarketBeat.com Staff From Our Partners"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestElon to Transform U.S. Economy? Porter & Company